Gyre Financial Statements From 2010 to 2026
| GYRE Stock | 8.30 0.37 4.67% |
Check Gyre Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gyre Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Gyre financial statements analysis is a perfect complement when working with Gyre Therapeutics Valuation or Volatility modules.
Check out the analysis of Gyre Therapeutics Correlation against competitors. Gyre Therapeutics Company Profit Margin Analysis
Gyre Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Gyre Therapeutics Profit Margin | 0.06 % |
Most of Gyre Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gyre Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Gyre Therapeutics has a Profit Margin of 0.062%. This is 100.55% lower than that of the Biotechnology sector and 100.27% lower than that of the Health Care industry. The profit margin for all United States stocks is 104.88% lower than that of the firm.
Gyre Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gyre Therapeutics's current stock value. Our valuation model uses many indicators to compare Gyre Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gyre Therapeutics competition to find correlations between indicators driving Gyre Therapeutics's intrinsic value. More Info.Gyre Therapeutics is rated # 3 in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Gyre Therapeutics is roughly 1.90 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Gyre Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Gyre Therapeutics Financial Statements
Gyre Therapeutics stakeholders use historical fundamental indicators, such as Gyre Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Gyre Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Gyre Therapeutics' assets and liabilities are reflected in the revenues and expenses on Gyre Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Gyre Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Gyre Therapeutics is a strong investment it is important to analyze Gyre Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gyre Therapeutics' future performance. For an informed investment choice regarding Gyre Stock, refer to the following important reports:Check out the analysis of Gyre Therapeutics Correlation against competitors. For information on how to trade Gyre Stock refer to our How to Trade Gyre Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gyre Therapeutics. If investors know Gyre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gyre Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Gyre Therapeutics is measured differently than its book value, which is the value of Gyre that is recorded on the company's balance sheet. Investors also form their own opinion of Gyre Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Gyre Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gyre Therapeutics' market value can be influenced by many factors that don't directly affect Gyre Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gyre Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.